Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 1/20 | 0.36 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.35 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.35 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ECE1 | P42892 | 1/20 | 0.35 |
| ▸ | TOP1 | P11387 | 4/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 4/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CASP1 | P29466 | 1/20 | 0.33 |
| ▸ | CASP7 | P55210 | 1/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.33 |
| ▸ | PDE4A | P27815 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19767416 | 0.99 | MAPT (0.36) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19767411 | 0.98 | MAPT (0.35) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19767407 | 0.96 | TOP1 (0.37) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19767413 | 0.96 | ATR (0.36) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19767408 | 0.96 | ATR (0.36) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19767410 | 0.95 | ATR (0.36) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL15581929 | 0.95 | TOP1 (0.38) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19165929 | 0.95 | TOP1 (0.38) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19486655 | 0.94 | TOP1 (0.37) | ATRPLA2G2APLA2G4APLA2G10MAPT | |
| SCHEMBL19767412 | 0.94 | TOP1 (0.37) | ATRPLA2G2APLA2G4APLA2G10MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-12 | — | — | US | disclosed |
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2018-04-12 | — | — | US | disclosed |
| US-9871206-B2 | Compound, organic electroluminescence device material, organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
| US-9871206-B2 | Compound, organic electroluminescence device material, organic electroluminescence device and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2018-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180102484-A1 | NEW COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC DEVICE | CBX8, MLX, HAX1 | ATR 1824/4885PLA2G2A 4473/4885PLA2G4A 4695/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.